EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Signal Pathways and microRNAs in Osteosarcoma Growth and the Dual Role of Mesenchymal Stem Cells in Oncogenesis

Natalia Todosenko, Igor Khlusov iD, Kristina Yurova, Olga Khaziakhmatova, Larisa Litvinova iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24108993 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Natalia Todosenko und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Immunology and Cellular Biotechnology, Immanuel Kant Baltic Federal University, 236001 Kaliningrad, Russia. Hauptthemen laut MEDLINE: MicroRNAs, Mesenchymal Stem Cells, Osteosarcoma, Bone Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 440 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: State Assignment Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The major challenges in Osteosarcoma (OS) therapy are its heterogeneity and drug resistance. The development of new therapeutic approaches to overcome the major growth mechanisms of OS is urgently needed. The search for specific molecular targets and promising innovative approaches in OS therapy, including drug delivery methods, is an urgent problem. Modern regenerative medicine focuses on harnessing the potential of mesenchymal stem cells (MSCs) because they have low immunogenicity. MSCs are important cells that have received considerable attention in cancer research. Currently, new cell-based methods for using MSCs in medicine are being actively investigated and tested, especially as carriers for chemotherapeutics, nanoparticles, and photosensitizers. However, despite the inexhaustible regenerative potential and known anticancer properties of MSCs, they may trigger the development and progression of bone tumors. A better understanding of the complex cellular and molecular mechanisms of OS pathogenesis is essential to identify novel molecular effectors involved in oncogenesis. The current review focuses on signaling pathways and miRNAs involved in the development of OS and describes the role of MSCs in oncogenesis and their potential for antitumor cell-based therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsMesenchymal Stem CellsOsteosarcomaBone NeoplasmsHumansSignal TransductionCell Transformation, NeoplasticCarcinogenesis

Stichwörter der Autor:innen

mesenchymal stem cellsmicroRNAsosteosarcomatreatment

Substanzen

MicroRNAs

Autor:innen und Institutionen

  • Center for Immunology and Cellular Biotechnology, Immanuel Kant Baltic Federal University, 236001 Kaliningrad, Russia.
  • Laboratory of Cellular and Microfluidic Technologies, Siberian State Medical University, 2, Moskovskii Trakt, 634050 Tomsk, Russia.

ORCID-Profile: Igor Khlusov, Larisa Litvinova

Förderung

  • State Assignment Grant

Zitieren

APA

Todosenko, N., Khlusov, I., Yurova, K., Khaziakhmatova, O., & Litvinova, L. (2023). Signal Pathways and microRNAs in Osteosarcoma Growth and the Dual Role of Mesenchymal Stem Cells in Oncogenesis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24108993

Vancouver

Todosenko N, Khlusov I, Yurova K, Khaziakhmatova O, Litvinova L. Signal Pathways and microRNAs in Osteosarcoma Growth and the Dual Role of Mesenchymal Stem Cells in Oncogenesis. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24108993

BibTeX
@article{Todosenko2023,
  author = {Todosenko, Natalia and Khlusov, Igor and Yurova, Kristina and Khaziakhmatova, Olga and Litvinova, Larisa},
  title = {Signal Pathways and microRNAs in Osteosarcoma Growth and the Dual Role of Mesenchymal Stem Cells in Oncogenesis},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24108993}
}
Kostenlos starten →